The beauty buffs have long coveted SkinCeuticals' luxe $182 C E Ferulic vitamin C serum, but with its patent recently expired, the high-end skincare staple may soon face competition from more affordable clones. Kelly Dobos, a cosmetic chemist and adjunct instructor at the University of Cincinnati, weighed in on the matter in a conversation with Business Insider. According to Business Insider, Dobos said through UC News, "It's been such a popular and efficacious product, it's pretty clear that brands are going to try to duplicate that."
Although the patent is off the market, this doesn't necessarily mean that other brands will nail SkinCeuticals' secret sauce on the cheap. With consumers eager to snap up these prospective bargains, Dobos notes the original patent may be holding back the exact formulation's nuances, and that's something competitors might struggle to decode.
But there's a catch in this race to replicate. In an interview with Business Insider, Dobos highlighted the downside of such mimicry in the skincare world, "I do think the kind of dupe culture that we're in is hindering innovation in a way because it's taking time and resources away from it." According to UC News, the focus on dupe production, she argues, may be diverting much-needed attention from inventing the next breakthrough in skincare. "True, disruptive innovation takes time," she told Business Insider.
In the broader context, the surge in dupes can be a double-edged sword for the beauty industry. By putting so much effort into trying to imitate what's already out there, brands could be selling both their potential revolutionary products and consumers short, as they fail to commit to researching and developing new, groundbreaking formulas. It is in these labs, often shrouded in a certain secrecy similar to their own patented concoctions, where the future of skincare is truly shaped.
